Related Experiment Videos
[TGF-beta and its receptors]
1Dept. of Hygiene, Tokyo Medical and Dental University School of Medicine.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 6, 1997
Abstract:
TGF-beta is a member of a superfamily associated with development and regulation of cell growth. Recently, its two receptors and intracellular components of signal transduction, a Smad family, have been identified. The type II receptor gene has been found to be mutated specifically in hereditary colon cancers, HNPCC. Alterations of the Smad 4 gene were also detected in pancreatic and colorectal cancers.
Insights
Transforming growth factor-beta (TGF-beta) signaling is crucial for cell growth. Mutations in its receptor and Smad 4 gene are linked to hereditary colon, pancreatic, and colorectal cancers.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Context:
- Transforming growth factor-beta (TGF-beta) is a key regulator of cell growth and development.
- The TGF-beta signaling pathway involves specific receptors and intracellular Smad proteins.
- Genetic alterations in this pathway are implicated in various human cancers.
Purpose:
- To investigate the role of TGF-beta pathway components in cancer development.
- To identify specific mutations in TGF-beta receptors and Smad genes associated with hereditary and sporadic cancers.
Summary:
- The type II TGF-beta receptor gene exhibits specific mutations in hereditary nonpolyposis colorectal cancer (HNPCC).
- Alterations in the Smad 4 gene, an intracellular signaling component, have been observed in pancreatic and colorectal cancers.
- These findings highlight the TGF-beta signaling pathway as a critical player in gastrointestinal tumorigenesis.
Impact:
- Identifies key genetic targets for cancer research and potential therapeutic strategies.
- Provides insights into the molecular mechanisms underlying hereditary and sporadic colorectal and pancreatic cancers.
- Underscores the importance of the TGF-beta pathway in maintaining cellular homeostasis and preventing cancer.